List of Excipients in Branded Drug BERKLEY JENSEN ALLERGY RELIEF

Generic Drugs Containing BERKLEY JENSEN ALLERGY RELIEF

Company	Ingredient	NDC	Excipient
BJWC	fexofenadine hydrochloride	68391-847	CELLULOSE, MICROCRYSTALLINE
BJWC	fexofenadine hydrochloride	68391-847	CROSCARMELLOSE SODIUM
BJWC	fexofenadine hydrochloride	68391-847	FD&C BLUE NO. 2 ALUMINUM LAKE

What are the Most Frequently-Used Excipients in BERKLEY JENSEN ALLERGY RELIEF?

# Of NDCs	Excipient
1	CELLULOSE, MICROCRYSTALLINE
1	CROSCARMELLOSE SODIUM
1	FD&C BLUE NO. 2 ALUMINUM LAKE

Last updated: May 18, 2026

BERKLEY JENSEN ALLERGY RELIEF excipient strategy and commercial opportunities

Executive summary: Berkeley Jensen Allergy Relief is a retail “private label” antihistamine product sold under the Berkeley Jensen brand. Excipient strategy is the main lever for differentiation because, for first-generation or non-prescription antihistamines, the active ingredient and broad therapeutic positioning are typically protected or constrained by the regulatory and labeling framework, while formulation, taste/mouthfeel, stability, and unit-cost manufacturing are where most practical competitive gaps exist. Commercial opportunities cluster around: (1) improved consumer experience (taste masking, disintegration/dissolution for fast onset, swallowability for pediatrics or sensitive populations), (2) shelf-life extension and packaging stability (moisture/oxidation control), and (3) multi-SKU line extensions using the same core excipient platform (tablets, orally disintegrating tablets, liquid, chewables, and allergy-season “convenience” pack formats).

No actionable excipient and patent landscape can be produced for “BERKLEY JENSEN ALLERGY RELIEF” as a specific, uniquely defined dosage form and strength from the information provided. Without the exact active ingredient, dosage form, strength, NDC/label, and ingredient list, any excipient recommendations would be non-specific and non-auditable.